By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Syrrx, Inc. 

10410 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-622-8528 Fax: 858-550-0526



Company News
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) To Acquire Syrrx, Inc.10/19/2005 5:12:38 PM
Syrrx, Inc. Researchers Report Atomic Structure Of Human HSD-1, An Important Target For The Potential Treatment Of Diabetes10/19/2005 5:12:05 PM
Syrrx, Inc. Researchers Report Atomic Structure Of c-KIT In Complex With Gleevec10/19/2005 5:11:54 PM
PPD, Inc. (PPDI) And Syrrx, Inc. File Investigational New Drug Application For DPP IV Inhibitor To Treat Type II Diabetes10/19/2005 5:11:50 PM
Syrrx, Inc. Announces Research Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) And Receives First Success Payment10/19/2005 5:11:32 PM
Roche (RHHBY) And Syrrx, Inc. Initiate Strategic Alliance In Diabetes And Cancer10/19/2005 5:11:16 PM
Syrrx, Inc. Awarded ATP Grant To Pursue High-Throughput Crystallization Of Membrane Proteins Using Heterogenous Nucleants10/19/2005 5:11:11 PM
Syrrx, Inc. Receives Second And Third Success Payments And Announces Completion Of Research Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB)10/19/2005 5:11:01 PM
PPD, Inc. (PPDI) And Syrrx, Inc. Collaborate To Develop Orally-Delivered DP4 Inhibitors To Treat Diabetes And Other Major Diseases10/19/2005 5:10:49 PM
Fluidigm Corporation Granted Non-Exclusive Sublicense To Syrrx, Inc.'s Nanovolume Crystallization(R) Patents10/19/2005 5:09:55 PM